Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the …
PL Moro, X Yue, P Lewis, P Haber, K Broder - Vaccine, 2011 - Elsevier
BACKGROUND: Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the …
PL Moro, X Yue, P Lewis, P Haber, K Broder - Vaccine, 2011 - pubmed.ncbi.nlm.nih.gov
Background Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
[引用][C] Adverse events after Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine administered to adults 65 years of age and older …
PL MORO, XIN YUE, P LEWIS, P HABER… - Vaccine, 2011 - pascal-francis.inist.fr
Adverse events after Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap)
Vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse …
Vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse …
Adverse events after Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the …
PL Moro, X Yue, P Lewis, P Haber, K Broder - 2011 - cabidigitallibrary.org
Background: Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the …
PL Moro, X Yue, P Lewis, P Haber, K Broder - Vaccine, 2011 - europepmc.org
Background Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
Adverse events after Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine administered to adults 65 years of age and older reported to …
PL Moro, X Yue, P Lewis, P Haber, K Broder - Vaccine, 2011 - infona.pl
Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine was not
licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy and safety data …
licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy and safety data …